Pajjiż: Ingilterra
Lingwa: Ingliż
Sors: MHRA (Medicines & Healthcare Products Regulatory Agency)
Lactulose
Esteve Pharmaceuticals Ltd
A06AD11
Lactulose
666.667mg/1ml
Oral solution
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 01060400; GTIN: 5015664500815
PACKAGE LEAFLET: INFORMATION FOR THE USER LACTULOSE 10 G/15 ML ORAL SOLUTION SACHETS LACTULOSE READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist have told you. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. - You must talk to a doctor if you do not feel better or if you feel worse after 3 days. WHAT IS IN THIS LEAFLET 1. What Lactulose is and what it is used for 2. What you need to know before you take Lactulose 3. How to take Lactulose 4. Possible side effects 5. How to store Lactulose 6. Contents of the pack and other further Information 1. WHAT LACTULOSE IS AND WHAT IT IS USED FOR Lactulose 10 g/15 ml oral solution sachets contain a laxative called lactulose. It makes the stool softer and easier to pass, by drawing water into the bowel. It is not absorbed into your body. Lactulose is indicated in adults and in children and adolescents aged 7 to 18 years. For children below 7 years, other dosage forms are available. Lactulose is used to treat the symptoms of constipation. You must talk to a doctor if you do not feel better or if you feel worse after 3 days. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE LACTULOSE DO NOT TAKE LACTULOSE: - if you are allergic to lactulose or any of the other ingredients of this medicine (listed in section 6). - if you suffer from galactosaemia (a severe genetic disorder where you cannot digest galactose), acute inflammatory bowel disease (like Crohn's disease or ulcerative colitis), blockage in your bowel (apart from normal constipation), digestive perforation or risk of digestive perforation or unexplained abdominal pain. WARNINGS AND PRECAUTIONS Talk to your doctor or pharmacist before taking Lactulose. Pl Aqra d-dokument sħiħ
OBJECT 1 LACTULOSE 10 G / 15 ML ORAL SOLUTION SACHETS Summary of Product Characteristics Updated 25-Jan-2017 | Intrapharm Laboratories Limited 1. Name of the medicinal product Laevolac 10 g/15 ml oral solution Lactulose 10 g/15 ml oral solution sachets 2. Qualitative and quantitative composition One sachet (15 ml) contains 10 g lactulose (as lactulose liquid). 3. Pharmaceutical form Oral solution Clear colourless to pale brownish yellow, viscous solution 4. Clinical particulars 4.1 Therapeutic indications • Symptomatic treatment of constipation Laevolac is indicated in adults and in children and adolescents aged 7 to 18 years. For children below 7 years, other dosage forms are available. 4.2 Posology and method of administration Posology Laevolac may be administered diluted or undiluted. The dose should be titrated according to the clinical response. Lactulose may be given as a single daily dose or in two to three divided doses. A single dose of lactulose should be swallowed in one and should not be kept in the mouth for an extended period of time. The posology should be adjusted according to the individual needs of the patient. The starting dose can be adjusted after adequate treatment effect individually (maintenance dose). Several days (2-3 days) of treatment may be needed in some patients before adequate treatment effect occurs. In case of single daily dose, this should be taken at the same time of the day, e.g. during breakfast. During the therapy with laxatives it is recommended to drink sufficient amounts of fluids (1.5-2 l/day, equal to 6-8 glasses). If diarrhoea occurs, the dosing regimen should be reduced. The duration of treatment has to be adopted according to the symptoms. Starting dose Maintenance dose Adults 15-45 ml daily 1-3 sachets, 15-30 ml daily 1-2 sachets, corresponding to 10-30 g lactulose corresponding to 10- 20 g lactulose Older people In elderly patients no special dosage recommendations exist. Patients with renal or hepatic impairment In patients with renal or hepatic insufficiency no Aqra d-dokument sħiħ